the aid library

LIST OPTIONS

Filter

8687

Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study

Alves J.D., Abade A.S., Peres W.P. et al. Cambridge University Press (2021) CC

This study aimed to analyze the geographical distribution of coronavirus disease 2019 (COVID-19) and to identify high-risk areas in space and time for the occurrence of cases and deaths in the indigenous population of Brazil. This is an ecological study carried out between 24 March and 26 October 20... more

Download (176)

View PDF (167)

Financing Health for All: Increase, transform and redirect - The WHO Council on the Economics of Health for all - Council Brief No. 2

World Health Organisation (WHO) (2021) C_WHO

The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop... more

External Link

Social Appropriation of Knowledge and its contributions to the prevention of cutaneous leishmaniasis in rural contexts

Paipilla, K., Castro-Arroyave, D., Grajales,L. et al. BMJ Innovations :234–239. doi:10.1136bmj (2022) CC

Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ... more

Download (325)

View PDF (277)

The future of WHO Covid-19 response operations in Africa in 2022
recommended

World Health Organization WHO, Regional Office of Africa (2022) C_WHO

The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Philippine Action Plan to Combat AMR: One Health Approach

Phillipine Department of Health (2019) C_WHO

Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c... more

Download (153)

View PDF (178)

Target product profile for readers of rapid diagnostic tests

World Health Organisation (WHO) (2023) C_WHO

Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the management and diagnosis of infectious diseases, including malaria, HIV and COVID-19. Visually interpreted RDTs, more than any other class of diagnostics, fulfil WHO’s ASSURED criteria,1 enabling their... more

Download (196)

View PDF (220)

Use of non-sugar sweeteners: WHO guideline

World Health Organisation (WHO) World Health Organisation (WHO) (2023) C_WHO

This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no... more

Download (426)

View PDF (478)

User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (‎C4P-HPV tool)

World Health Organisation (WHO) (2023) C_WHO

Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin... more

Download (182)

View PDF (217)

Contingency Fund for Emergencies 2022 annual report Enabling quick action to save lives

World Health Organisation (WHO) (2023) C_WHO

The Contingency Fund for Emergencies (CFE) provides WHO with rapid and flexible resources to respond to disease outbreaks and other health emergencies. The annual report provides an overview of the use and impact of the Fund over the previous year.

Download (461)

View PDF (704)

Comfort for Kids in the Time of Ebola : Mental Health Liberia

World Bank (2018) C1

The 2014-2015 outbreak of Ebola virus disease (EVD) in Liberia resulted in over 10,000 cases and 5,000 deaths. Recognizing the importance of addressing children’s trauma, the Ebola recovery and restoration trust fund (EERTF) funded the implementation of a Comfort for kids (C4K) program which encou... more

Download (204)

View PDF (222)

Краткое руководство по видеосопровождению при лечении туберкулеза

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

Quick guide to video-supported treatment of tuberculosis (2020). Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’... more

Download (1820)

View PDF (2146)

Study on the Gendered Impacts of Ebola in Liberia (February 2015)

Leena Kotilainen Finn Church Aid (2015)

This study examines the gendered impacts of the Ebola virus disease (EVD) in Liberia in the largest outbreak of EVD ever recorded. The findings are based on an extensive two-week desk study and one-week participatory field study conducted in January 2015 in the cities of Monrovia and Buchanan in Lib... more

Download (286)

View PDF (262)

Global oral health status report: towards universal health coverage for oral health by 2030: regional summary of the Western Pacific Region

World Health Organisation (WHO) (2023) C_WHO

This regional summary draws on the WHO Global oral health status report (2), published in 2022, which provides a comprehensive overview of the global oral disease burden, the global health importance of oral health and the impact of oral diseases over the life course. The summary focuses on the ... more

Download (4030)

View PDF (5663)

Kenya Essential Medicines List 2019
recommended

Ministry of Health, Kenya (2019) C1

The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit... more

Download (455)

View PDF (615)

Business case for WHO immunization activities on the African continent 2018-2030

World Health Organization (WHO) (2018) C_WHO

The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been translated into firm commitments in February 2016, t... more

Download (266)

View PDF (222)

Pig management: Ensuring appropriate husbandry practices for profitability

Lawrence Mayega, Michel M. Dione, Brian Kawuma, et al. International Livestock Research Institute ILRI (2015) C2

Training manual that outlines the training of smallholder farmers to improve biosecurity and practices in their farms to prevent infectious diseases and thus the need for use of veterinary drugs. Describes training sessions and includes exercises and handouts.

Download (67)

View PDF (54)

Guidelines for the treatment of human African trypanosomiasis
recommended

World Health Organization WHO (2024) C_WHO

The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms. HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as... more

Download (276)

View PDF (334)

The Burden of Mental Disorders in the Region of the Americas

World Health Organization, Pan American Health Organization (2018) C_WHO

This report aims to improve the assessment of mental health needs in the Americas by providing an updated and nuanced picture of: (a) the disability resulting from mental, substance use, and specific neurological disorders, plus self-harm, alone and in combination with premature mortality; (b) the i... more

Download (325)

View PDF (423)

The Socio-Economic Impact of People Living with HIV at the Household Level in Myanmar

Cercone, James; Pinder, Étoile; Pothuis, Michal et al. The Republic of the Union of Myanmar, Ministry of Health and Sports; UNDP (2016) C1

The study collected data on the impact of HIV-related diseases on income, revenues, economic dependency, consumption, education, health, food security, stigma, discrimination, quality of life, and migration. The study also assessed people living with chronic diseases in order to compare the impact o... more

The future of WHO Covid-19 response operations in Africa in 2022 recommended

Kenya Essential Medicines List 2019 recommended

Guidelines for the treatment of human African trypanosomiasis recommended

The future of WHO Covid-19 response operations in Africa in 2022
recommended

Kenya Essential Medicines List 2019
recommended

Guidelines for the treatment of human African trypanosomiasis
recommended